# MWG Management Ltd.

> Institutional holdings reported to the SEC as of Q3 2025 on Form 13F. CIK 1845151. Source: https://holderbook.com/funds/1845151-mwg-management-ltd/

- Reported value: $81.3M
- Positions: 3
- Weight of the ten largest: 100.0%
- Filed: 2025-11-12

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| BEAM THERAPEUTICS INC | [BEAM](https://holderbook.com/stocks/BEAM/) | $55.0M | 2,266,934 | 67.7% | 20 |
| LYELL IMMUNOPHARMA INC | [LYEL](https://holderbook.com/stocks/LYEL/) | $16.4M | 1,008,116 | 20.1% | 1 |
| PRIME MEDICINE INC | [PRME](https://holderbook.com/stocks/PRME/) | $9.9M | 1,792,210 | 12.2% | 12 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2025 | $81.3M | 3 |
| Q2 2025 | $51.9M | 3 |
| Q1 2025 | $58.7B | 3 |
| Q4 2024 | $74.4B | 3 |
| Q3 2024 | $90.3M | 3 |
| Q2 2024 | $91.6M | 3 |
| Q1 2024 | $135.1M | 3 |
| Q4 2023 | $118.9M | 3 |
| Q3 2023 | $103.2M | 3 |
| Q2 2023 | $165.3M | 3 |
| Q1 2023 | $142.0M | 3 |
| Q4 2022 | $195.9M | 3 |